Prescription drug monitoring /
Annotation
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Hauppauge, N.Y. :
Nova Science,
2013.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- PRESCRIPTION DRUG MONITORING; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Prescription Drug Monitoring Programs*; Summary; Introduction; Prescription Drug Monitoring Programs (PDMPs); Program Operation; Interstate Information Sharing and Interoperability; Compliance and Enforcement Mechanisms; Program Costs; PDMP Financing; PDMP Effectiveness; Effectiveness Research; Limitations of the Research; Potential Unintended Consequences; Potential to Increase Effectiveness; Federal Grant Programs for State PDMPs; Harold Rogers PDMP; Grant Purpose Areas.
- AppropriationsNational All Schedules Prescription Electronic Reporting Act of 2005 (NASPER); Grant Purpose Areas; Appropriations; Program Comparison; Selected Policy Issues; Role of PDMPs in the Federal Prescription Drug Abuse Strategy; Balancing Stakeholder Concerns; Federal Role in Interstate Information Sharing and Interoperability; End Notes; Chapter 2: Statement of John L. Eadie, Director, Prescription Drug Monitoring Program Center of Excellence, Brandeis University. Hearing on ''Prescription Drug Abuse''*; I. The Center; II. Prescription Drug Monitoring Programs
- A brief overview.
- III. PDMPs are for both Public Health and Public SafetyIV. A New Generation of PDMPs: Adopting Best Practices; IV. A. Proactive, Unsolicited Reports; IV. B. Prescribers and Pharmacists:; Requested (Solicited) Reports; IV. C. Law Enforcement Agencies: Requested (Solicited) Reports; IV. D. Health Professional Licensing Agencies; IV. E. Pharmacies: Verifications Prior to Dispensing; IV. F. Expanding PDMP Data Use to Other Users; IV. G. Interstate PDMP Data Sharing; V. Prescription Behavior Surveillance System; V.A. Early Warning System; VI. Third Party Health Care Payers and PDMPs.
- VII. Mandatory Prescriber EducationVIII. Issues the Senate Caucus on International Narcotic Control Might Consider; Chapter 3: Prescription Drug Data: HHS Has Issued Health Privacy and Security Regulations but Needs to Improve Guidance and Oversight*; Why GAO Did This Study; What GAO Recommends; What GAO Found; Abbreviations; Background; Prescription Drug Use Information Can Be Used for Purposes Other than Direct Clinical Care.
- Federal Laws Establish Privacy and Security Protections of Individually Identifiable Health Information Including Prescription Drug Use Information Used for Purposes Other than Direct Clinical CareHHS Has a Framework for Protecting Medicare Beneficiaries' Prescription Drug Use Information but Has Not Issued Required Guidance or Implemented Required Oversight Capabilities; HHS Issued Regulations to Implement Key HIPAA and HITECH Act Requirements for Protecting PHI; HHS Issued the HIPAA Privacy and Security Rules to Meet HIPAA Requirements.